Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Medical use of cannabis in the Netherlands

Medical use of cannabis in the Netherlands Abstract—The authors investigated the indications for cannabis prescription Medical use of in the Netherlands and assessed its efficacy and side effects. A majority cannabis in the (64.1%) of patients reported a good or excellent effect on their symptoms. Of these patients, approximately 44% used cannabis for 5 months. Indications Netherlands were neurologic disorders, pain, musculoskeletal disorders, and cancer anorex- ia/cachexia. Inhaled cannabis was perceived as more effective than oral admin- istration. Reported side effects were generally mild. NEUROLOGY 2005;64:917–919 Robert W. Gorter, MD, PhD; Mario Butorac, MA; Eloy Pulido Cobian, MD; and Willem van der Sluis, PhD There has been renewed interest in the medical use used cannabis occasionally vs 13% of all patients of Cannabis sativa and its main constituent, -9- with MS who responded. tetrahydrocannabinol (THC), for conditions like an- In the Netherlands, recreational use of cannabis is 1,2 orexia and cachexia in cancer and AIDS, movement illegal, but consumption of small amounts under cer- 3,4,5 disorders and multiple sclerosis (MS), migraine, tain conditions is condoned. Medical use of cannabis spinal cord injuries, and pain. was legalized in 2003, so physicians now prescribe In 1997, 112 patients with MS in the USA and the cannabis to patients http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurology Wolters Kluwer Health

Medical use of cannabis in the Netherlands

Neurology , Volume 64 (5) – Mar 1, 2005

Loading next page...
 
/lp/wolters-kluwer-health/medical-use-of-cannabis-in-the-netherlands-DMj560UfCV

References (15)

ISSN
0028-3878
eISSN
1526-632X
DOI
10.1212/01.WNL.0000152845.09088.28
pmid
15753439
Publisher site
See Article on Publisher Site

Abstract

Abstract—The authors investigated the indications for cannabis prescription Medical use of in the Netherlands and assessed its efficacy and side effects. A majority cannabis in the (64.1%) of patients reported a good or excellent effect on their symptoms. Of these patients, approximately 44% used cannabis for 5 months. Indications Netherlands were neurologic disorders, pain, musculoskeletal disorders, and cancer anorex- ia/cachexia. Inhaled cannabis was perceived as more effective than oral admin- istration. Reported side effects were generally mild. NEUROLOGY 2005;64:917–919 Robert W. Gorter, MD, PhD; Mario Butorac, MA; Eloy Pulido Cobian, MD; and Willem van der Sluis, PhD There has been renewed interest in the medical use used cannabis occasionally vs 13% of all patients of Cannabis sativa and its main constituent, -9- with MS who responded. tetrahydrocannabinol (THC), for conditions like an- In the Netherlands, recreational use of cannabis is 1,2 orexia and cachexia in cancer and AIDS, movement illegal, but consumption of small amounts under cer- 3,4,5 disorders and multiple sclerosis (MS), migraine, tain conditions is condoned. Medical use of cannabis spinal cord injuries, and pain. was legalized in 2003, so physicians now prescribe In 1997, 112 patients with MS in the USA and the cannabis to patients

Journal

NeurologyWolters Kluwer Health

Published: Mar 1, 2005

There are no references for this article.